Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
Business Wire (Tue, 29-Sep 8:08 AM ET)
TipRanks (Mon, 28-Sep 6:25 AM ET)
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Centene in focus
Seeking Alpha News (Sun, 27-Sep 9:05 AM ET)
Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)
TipRanks (Sat, 26-Sep 8:40 AM ET)
Stock futures lower after Wall Street selloff
Seeking Alpha News (Thu, 24-Sep 4:11 AM ET)
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
Business Wire (Mon, 21-Sep 8:00 AM ET)
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share
Business Wire (Wed, 16-Sep 6:59 PM ET)
Agilent Announces Cash Dividend of 25.5 Cents per Share
Business Wire (Wed, 16-Sep 4:15 PM ET)
Agilent to Participate in J.P. Morgan U.S. All Stars Conference
Business Wire (Thu, 10-Sep 4:15 PM ET)
Business Wire (Tue, 8-Sep 8:00 AM ET)
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Agilent Technologies trades on the NYSE stock market under the symbol A.
As of September 29, 2026, A stock price declined to $175.01 with 558,554 million shares trading.
A has a beta of 0.86, meaning it tends to be less sensitive to market movements. A has a correlation of 0.09 to the broad based SPY ETF.
A has a market cap of $49.39 billion. This is considered a Large Cap stock.
Last quarter Agilent Technologies reported $2 billion in Revenue and $1.62 earnings per share. This beat revenue expectation by $37 million and exceeded earnings estimates by $.14.
In the last 3 years, A traded as high as $177.05 and as low as $96.43.
The top ETF exchange traded funds that A belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
A has outperformed the market in the last year with a price return of +42.7% while the SPY ETF gained +16.5%. A has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +28.9% and +19.2%, respectively, while the SPY returned +5.0% and +0.6%, respectively.
A support price is $171.42 and resistance is $179.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that A shares will trade within this expected range on the day.